Headline;Month;Day
Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin;4;3
The Diagnosis Is Alzheimer’s. But That’s Probably Not the Only Problem.;4;8
Drugmaker Deals Are Near Record Pace in 2019, but Investors Don’t Love Them All;6;27
Trump’s Efforts to Rein In Drug Prices Face Setbacks;7;11
Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit;10;9
Their Tax Rate Is 0%;4;15
Lawmakers in Both Parties Vow to Rein In Insulin Costs;4;10
Dr. John Mendelsohn, 82, Researcher Who Led Top Cancer Center, Dies;1;18
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal;6;25
Drug Prices Will Soon Appear in Many TV Ads;5;8
DealBook Briefing: A Model to Alleviate Student Debt Gains Traction;1;8
Why I Am Stockpiling Insulin in My Fridge;4;9
Dan Robbins, Who Made Painting as Easy as 1-2-3 (and 4-5-6), Dies at 93;4;5
White House Summons Feuding Health Officials for Counseling Session;12;10
Drug Prices on TV? They May Be Coming.;3;23
An Alzheimer’s Drug Trial Gave Me Hope, and Then It Ended;3;22
Warning of ‘Pig Zero’: One Drugmaker’s Push to Sell More Antibiotics;6;7
Drug Prices Are a Populist Campaign Issue. Here Are the Latest Proposals to Lower Costs.;6;16
Companies See Climate Change Hitting Their Bottom Lines in the Next 5 Years;6;4
Martin Feldstein, 79, a Chief Economist Under Reagan, Dies;6;12
Trump Administration Weighs Allowing Drug Imports for Cheaper Prescriptions;7;31
DealBook Briefing: ‘Forecasting a Slowdown’ for 2019;1;15
DealBook Briefing: Corporate America Considers Its Role in Gun Violence;8;5
36 Hours in Indianapolis;11;14
Vast Dragnet Targets Theft of Biomedical Secrets for China;11;4
14 Pop, Rock and Jazz Concerts to Check Out in N.Y.C. This Weekend;2;28
Gen X Is a Mess;5;14
The Highest-Paid C.E.O.s of 2018: A Year So Lucrative, We Had to Redraw Our Chart;5;24
This Week’s Wedding Announcements;6;16
Runners-Up From Our Sixth Annual Student Editorial Contest;6;6
